Vivanza Biosciences Share Price
Start SIP in Vivanza Biosciences
Start SIPVivanza Biosciences Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Vivanza Biosciences Investment Rating
-
Master Rating:
-
Vivanza Biosciences has an operating revenue of Rs. 21.05 Cr. on a trailing 12-month basis. An annual revenue growth of 53% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 11% is good. The company has a debt to equity of 58%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 54 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 0 | 2 | 3 | 4 | 5 | 6 |
| Operating Expenses Qtr Cr | 0 | 2 | 3 | 4 | 4 | 6 |
| Operating Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Vivanza Biosciences Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹4.09
- 50 Day
- ₹4.51
- 100 Day
- ₹5.33
- 200 Day
- ₹6.80
- 20 Day
- ₹4.13
- 50 Day
- ₹4.44
- 100 Day
- ₹5.41
- 200 Day
- ₹6.96
Vivanza Biosciences Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 3.88 |
| Second Resistance | 3.92 |
| Third Resistance | 3.95 |
| RSI | 31.26 |
| MFI | 31.17 |
| MACD Single Line | -0.17 |
| MACD | -0.16 |
| Support | |
|---|---|
| First Support | 3.81 |
| Second Support | 3.78 |
| Third Supoort | 3.74 |
Vivanza Biosciences Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 59,200 | 5,920,000 | 100 |
| Week | 33,749 | 3,374,940 | 100 |
| 1 Month | 74,309 | 7,430,868 | 100 |
| 6 Month | 300,662 | 26,584,550 | 88.42 |
Vivanza Biosciences Result Highlights
Vivanza Biosciences Synopsis
BSE-Medical-Diversified
Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 14.41 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2024. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.| Market Cap | 15 |
| Sales | 10 |
| Shares in Float | 2.40 |
| No of funds | 2 |
| Yield |
| Book Value | 3.25 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 16 |
| Alpha | -0.64 |
| Beta | 0.21 |
Vivanza Biosciences Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 40.05% | 43.24% | 44.9% | 47.29% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 45.01% | 13.82% | 9.05% | 6.23% |
| Others | 14.94% | 42.94% | 46.05% | 46.48% |
Vivanza Biosciences Management
| Name | Designation |
|---|---|
| Mr. J A Mehta | Managing Director |
| Mr. H A Parikh | Director |
| Ms. Rina Kumari | Director |
| Mr. A P Shah | Director |
Vivanza Biosciences Forecast
Price Estimates
Vivanza Biosciences Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-08 | Quarterly Results | |
| 2024-07-05 | Others | Inter alia, 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; split from Rs. 10/- to Re. 1/-. |
| 2024-04-30 | Audited Results | |
| 2024-02-06 | Quarterly Results | |
| 2023-10-26 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-03-24 | Split | Rs.0.00 split from Rs. 10/- to Re. 1/-. |
Vivanza Biosciences FAQs
What is Share Price of Vivanza Biosciences ?
Vivanza Biosciences share price is ₹3 As on 19 September, 2024 | 13:22
What is the Market Cap of Vivanza Biosciences ?
The Market Cap of Vivanza Biosciences is ₹15.2 Cr As on 19 September, 2024 | 13:22
What is the P/E ratio of Vivanza Biosciences ?
The P/E ratio of Vivanza Biosciences is 47.7 As on 19 September, 2024 | 13:22
What is the PB ratio of Vivanza Biosciences ?
The PB ratio of Vivanza Biosciences is 3.3 As on 19 September, 2024 | 13:22